Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

A double-blind, placebo-controlled, randomized human study assessing the capacity of a novel galacto-oligosaccharide mixture in reducing travellers' diarrhoea

European Journal of Clinical Nutrition volume 64, pages 146–152 (2010)Cite this article

Abstract

Background/Objectives:

Prebiotics have attracted interest for their ability to positively affect the colonic microbiota composition, thus increasing resistance to infection and diarrhoeal disease. This study assessed the effectiveness of a prebiotic galacto-oligosaccharide mixture (B-GOS) on the severity and/or incidence of travellers' diarrhoea (TD) in healthy subjects.

Subjects/Methods:

The study was a placebo-controlled, randomized, double blind of parallel design in 159 healthy volunteers, who travelled for minimum of 2 weeks to a country of low or high risk for TD. The investigational product was the B-GOS and the placebo was maltodextrin. Volunteers were randomized into groups with an equal probability of receiving either the prebiotic or placebo. The protocol comprised of a 1 week pre-holiday period recording bowel habit, while receiving intervention and the holiday period. Bowel habit included the number of bowel movements and average consistency of the stools as well as occurrence of abdominal discomfort, flatulence, bloating or vomiting. A clinical report was completed in the case of diarrhoeal incidence. A post-study questionnaire was also completed by all subjects on their return.

Results:

Results showed significant differences between the B-GOS and the placebo group in the incidence (P<0.05) and duration (P<0.05) of TD. Similar findings occurred on abdominal pain (P<0.05) and the overall quality of life assessment (P<0.05).

Conclusions:

Consumption of the tested galacto-oligosaccharide mixture showed significant potential in preventing the incidence and symptoms of TD.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  • Black RE (1990). Epidemiology of travellers' diarrhea and relative importance of various pathogens. Rev Infect Dis 12, S73–S79.

    Article  Google Scholar 

  • Buddington KK, Danohoo JB, Buddington RK (2002). Dietary oligofructose and inulin protect mice from enteric and systemic pathogens and tumour inducers. J Nutr 132, 472–477.

    Article  CAS  Google Scholar 

  • Center for Disease Control and Prevention (CDC) (2008). Prevention of specific infectious diseases. In: CDC Health Information for International Travel. Atlanta, GA.

  • Cremonini F, Di Caro S, Nista EC (2002). Meta-analysis: the effect of probiotic administration on antibiotic associated diarrhea. Aliment Pharmacol Ther 16, 1461–1467.

    Article  CAS  Google Scholar 

  • Cummings JH, Christie S, Cole JT (2001). A study of fructooligosacharides in the prevention of travellers' diarrhea. Aliment Pharmacol Ther 15, 1139–1145.

    Article  CAS  Google Scholar 

  • Depeint F, Tzortzis G, Vulevic J, I'anson K, Gibson GR (2008). Prebiotic evaluation of a novel galacto-oligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIM 41171, in healthy humans. Am J Clin Nutr 87 (Suppl, 3), S785–S791.

    Article  Google Scholar 

  • DuPont HL (2001). Treatment of travellers' diarrhea. J Travel Med 8, S31–S33.

    Article  CAS  Google Scholar 

  • DuPont HL, Capsuto EG (1996). Persistent diarrhea in travellers. Clin Infect Dis 22, 124–128.

    Article  CAS  Google Scholar 

  • Gibson GR, McCartney AL, Rastall RA (2005). Prebiotics and resistance to gastrointestinal infections. Br J Nutr 93, S31–S34.

    Article  CAS  Google Scholar 

  • Gibson GR, Roberfroid MB (1995). Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125, 1401–1412.

    Article  CAS  Google Scholar 

  • Huang JS, Bousvaros A, Lee JW, Diaz A, Davidson EJ (2002). Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci 47, 2625–2634.

    Article  CAS  Google Scholar 

  • Kamat D, Mathur A (2006). Prevention and management of travellers' diarrhea. Travel Med 52 (Suppl, 7), 289–302.

    Google Scholar 

  • Kunz C, Rudloff S, Baier W, Klein N, Strobel S (2000). Oligosaccharides in human milk: structural functional, and metabolic aspects. Ann Rev Nutr 20, 699–722.

    Article  CAS  Google Scholar 

  • Paredes P, Campbell-Forrester S, Mathewson JJ, Ashley D, Thompson S, Steffen R et al. (2000). Etiology of travellers' diarrhea on a Caribbean Island. J Travel Med 7, 15–18.

    Article  CAS  Google Scholar 

  • Peltola H, Gorbach SL (2001). Travellers' diarrhea epidemiology and clinical aspects. In: Dupont H, Steffen R (eds). Textbook of Travel Medicine and Health. BC Decker Inc, Hamilton: Canada. pp 151–159.

    Google Scholar 

  • Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH (1994). Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhea and shedding of rotavirus. Lancet 344, 1046–1049.

    Article  CAS  Google Scholar 

  • Searle LEJ, Best A, Nunez A, Salguero FJ, Johnson L, Weyer U et al. (2009). A galacto-oligosaccharide mixture, produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, reduces Salmonella Typhimurium infection in mice. J Med Microb 58, 37–48.

    Article  Google Scholar 

  • Silk DBA, Davis A, Vulevic J, Tzortzis G, Gibson GR (2009). Clinical trial: the effect of a trans-galactooligosacharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther 29, 508–518.

    Article  CAS  Google Scholar 

  • Steffen R, Van Der Linde F, Gyr K, Schär M (1983). Epidemiology of diarrhea in travellers. JAMA 249, 1176–1180.

    Article  CAS  Google Scholar 

  • Tojo M, Oikawa T, Morikawa Y, Yamashita N, Iwata S, Satoh Y (1987). The effects of Bifidobacterium breve administration on Campylobacter enteritis. Acta Pediatr Jpn 29, 160–167.

    Article  CAS  Google Scholar 

  • Tzortzis G, Goulas AK, Gee JM, Gibson GR (2005). A novel galactooligosaccharide mixture increases the bifidobacterial population numbers in a continuous in vitro fermentation system and in the proximal colon of pigs in vivo. J Nutr 135, 1726–1731.

    Article  CAS  Google Scholar 

  • U.S. Food and Drug Administration (2008). Center for Food Safety and Applied Nutrition. Office of Food Additive Safety. Version 28 July, 2008. GRAS Notice No. CRN 000236. Internet: http://www.cfsan.fda.gov/∼rdb/opa-g236.html (accessed 06 November 2008).

  • Vila J, Vargas M, Ruiz J, Corachan M, Jimenez De Anta MT, Gascon J (2000). Quinolone resistance in enterotoxigenic Escherichia coli causing diarrhea in travellers to India in comparison with other geographical areas. Antimicrob Agents Chemother 44, 1731–1733.

    Article  CAS  Google Scholar 

  • Vulevic J, Drakoularakou A, Yaqoob P, Tzortzis G, Gibson GR (2008). Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosacharide mixture (B-GOS) in healthy elderly volunteers. Am J Clin Nutr 88, 1438–1446.

    CAS  PubMed  Google Scholar 

  • World Health Organization (2004). WHOQOL Study Protocol. WHO 2004 MNH7PSF/93.9.

Download references

Acknowledgements

Financial support was offered through a grant from Clasado Ltd. All data were analysed by Dr Drakoularakou.

Author information

Authors and Affiliations

  1. Department of Food Biosciences, The University of Reading, Reading, UK

    A Drakoularakou, R A Rastall & G R Gibson

  2. Clasado Ltd, 5 Canon Harnett Court, Wolverton Mill, Milton Keynes, UK

    G Tzortzis

Authors
  1. A Drakoularakou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G Tzortzis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R A Rastall
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G R Gibson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Drakoularakou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drakoularakou, A., Tzortzis, G., Rastall, R. et al. A double-blind, placebo-controlled, randomized human study assessing the capacity of a novel galacto-oligosaccharide mixture in reducing travellers' diarrhoea. Eur J Clin Nutr 64, 146–152 (2010). https://doi.org/10.1038/ejcn.2009.120

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ejcn.2009.120

Keywords

This article is cited by

Search

Advanced search

Quick links